the bone marrow. All MR images shown were acquired with From the Departments of Diagnostic Radiology and Clinical relaxation time. By selecting the appropriate MR pulse se-Therapeutics, University of Athens, Medical School, Athens, Greece.
M a 1.5 T unit. AGNETIC RESONANCE (MR) imaging has become preferred over other imaging modalities in evaluating T1-weighted images. On T1-weighted MR images, tisdisease in the bone marrow. 1,2 It is a noninvasive technique sue contrast is determined primarily by T1 characteristics. that complements bone marrow aspirations and biopsies by Fat has a short T1 relaxation time and is hyperintense (bright) sampling a large volume of bone marrow and by providing on T1-weighted images. Fatty marrow, because it is cominformation that aids the diagnosis, staging, and follow-up posed primarily of fat, has a characteristic bright signal, of hematologic malignancies. similar to that of subcutaneous fat (Figs 1 and 2) . Water, on The MR imaging appearance of the bone marrow depends the other hand, has a long T1 relaxation time and is hypoinon the presence and relative proportions of trabecular bone, tense (dark) on T1-weighted images. Tissues rich in free fat, and water. Each of these constituents of the bone marrow water, such as cerebrospinal fluid, are dark on T1-weighted produces a different MR signal. It is the summation of these images. Red marrow is composed of 40% water, 40% fat, signals that creates the final MR image. Because the bone and 20% protein. On T1-weighted images, red marrow is marrow is a dynamic organ that changes continuously from considerably darker than fatty marrow and has a signal intenbirth through life, the MR appearance of the bone marrow sity similar to or slightly higher than muscle (Figs 1 and 2). 2 varies with age. The predictable rate and patterns of red
The bright signal of fatty marrow facilitates the detection of (hematopoietic) to yellow (fatty) marrow conversion and the marrow lesions, the vast majority of which have a longer unique characteristics of red and yellow marrow on MR T1 relaxation time than fat. 2 However, marrow lesions may images have allowed for the mapping of their age-related have similar T1 relaxation times to red marrow, and their distributions in the skeleton.
detection on a background of hematopoietic marrow may be Fatty replacement of the functioning hematopoietic mardifficult with T1-weighted MR images alone. row begins in the periphery of the appendicular skeleton and T2-weighted images. Fat has a short T2 relaxation time, proceeds centrally (Fig 1) . In the long bones, fatty marrow which means that, on T2-weighted images, in which T2 first appears in the diaphyses and epiphyses and later in the characteristics prevail, fat is dark and the signal intensity of metaphyses. [2] [3] [4] The adult pattern of red and yellow marrow fatty marrow decreases (Fig 2) . Water has a long T2 relaxdistribution is reached in the early 20s; hematopoietic maration time and is bright on T2-weighted images. The appearrow remains throughout life in the spine, sternum, ribs, pelance of red marrow on T2-weighted MR images varies vis, skull, calcaneus, and proximal metaphysis of the huslightly. 2 It usually shows a small increase in signal, becommerus and femur. In the adult, the involution of active ing slightly brighter than muscle. The vertebral bodies on hematopoietic tissue gradually continues. Red to yellow mar-T2-weighted images are darker than the intervertebral discs, row conversion may be diffuse or may occur in the form of unless the discs are degenerated (Fig 2) . isolated or confluent islands of fatty marrow (Fig 2) . 2, 4 In Fatty marrow is not readily distinguished from red marrow the spine, Ricci et al 4 described four distinct patterns of on T2-weighted images. 2 However, because most marrow marrow distribution and reported the relative frequency of lesions are rich in free water, they are brighter than both red each pattern in different age groups. and yellow marrow on T2-weighted images and are easily When there is a demand for additional hematopoiesis detected. 2 T2-weighted fast spin echo images have replaced (stress, chronic anemia, extensive marrow replacement, etc), conventional T2-weighted spin echo images in most instituconversion of yellow to red marrow is initiated. [2] [3] [4] [5] [6] [7] The protions, because they offer comparable image quality at shorter cess of reconversion progresses in a reverse pattern relative imaging times. 8 On T2-weighted fast spin echo images, fat is to conversion. It may occur diffusely or focal areas of red markedly brighter compared with conventional T2-weighted marrow may appear in a background of fatty marrow. 2 images; therefore, selective fat suppression is applied to fast Knowledge of patterns and causes of marrow reconversion spin echo T2-weighted images. is important and may explain an unusual peripheral location Short inversion-time-inversion-recovery (STIR) images. of a pathologic process of the red marrow. 3 STIR sequences can be used to eliminate the signal from a selected tissue. In the spine, nulling of the signal of lipid MR IMAGING OF THE NORMAL MARROW protons allows for better visualization of cellular lesions,
The MR signal depends on three parameters inherent to specific tissues: proton density, T1 relaxation time, and T2 is hardly perceptible on visual inspection and is easily differentiated from enhancement associated with marrow lesions (Figs 4 and 5) . 12, 13 Enhanced MR images are particularly useful for the detection of diffuse marrow abnormality that may not be recognized on unenhanced MR images. 14 They can also provide information on the status of the leptomeninges during the same examination and should be obtained whenever leptomeningeal disease is suspected. Postcontrast images do increase the cost and the duration of the MR study and should, therefore, be reserved for cases with unclear findings on the precontrast images. Precontrast and postcontrast T1-weighted images must be acquired and viewed with the same imaging parameters. Image subtraction and postcontrast T1-weighted images obtained with fat suppression facilitate the detection of abnormal enhancement. 15 It should be noted that, in the developing spine, enhancement of the marrow may be marked because of prominent blood supply, increased marrow cellularity, and an extensive extravascular space that allows contrast to pool. 13 In young children, care should be taken to avoid a diagnosis of a pathologic marrow state based solely on enhancement of the spinal marrow on MR images.
A standard MR imaging protocol for the bone marrow may include coronal STIR images of the spine and pelvis and sagittal T1-weighted and fat-suppressed, T2-weighted fast spin echo or STIR sagittal images of the spine. Axial and contrast-enhanced T1-weighted images may be acquired as needed.
MR IMAGING OF THE ABNORMAL MARROW
There are three MR patterns of abnormal marrow that reflect different types of histologic infiltration of the bone marrow. 2, 14 The focal pattern consists of localized areas of row and slightly darker or isointense to red marrow. On T2weighted images they are brighter than both red and yellow marrow, and on enhanced T1-weighted images they enhance which appear bright on a dark background ( Fig 3) . 8, 9 STIR to various degrees depending on the vascularity of the underimages have additive T1 and T2 characteristics, which means lying pathologic process. 2, 12 STIR and fat-saturation T2that tissues with long T1 and long T2 values will appear weighted images provide increased contrast between focal brighter on STIR than on T2-weighted spin echo images. lesions and uninvolved marrow. [8] [9] [10] [11] Therefore, compared with spin echo T2-weighted images,
In the diffuse MR pattern of abnormal marrow, the normal STIR images provide greater contrast between pathology bone marrow is completely replaced by the abnormal process and uninvolved bone marrow. 8, 9 Although they have reduced ( Fig 5) . 14 The intervertebral discs appear brighter or isoinsignal-to-noise ratios, they are less prone to motion artifacts tense to the diseased marrow. This pattern is typical for the because the signal from fat is suppressed. 9 STIR images acute leukemias. On T1-weighted images, there is a diffuse offer equal lesion conspicuity compared with fat-suppressed, decrease in the signal intensity of the marrow. In young T2-weighted sequences, but image acquisition per unit of adults, a diffuse MR pattern may be difficult to differentiate time is limited with the former. 10,11 The chemical shift-selecfrom pure hematopoietic marrow on T1-weighted images. tive fat suppression techniques used in fat-suppressed, T2-On T2-weighted images of diffuse patterns of marrow weighted fast spin echo images may cause field heterogeneinvolvement, a variable increase in the signal intensity of ity, particularly with large field-of-views. With large field-ofthe abnormal marrow is observed. This increase in signal view coronal STIR images, the axial skeleton can be imaged may be difficult to appreciate because there is no normal almost entirely and the status of a large volume of the bone marrow for comparison. After the administration of intravemarrow can be assessed (Fig 3) . nous contrast, the abnormal marrow enhances. 14 The inter-Contrast-enhanced T1-weighted images. In the adult, vertebral discs appear darker than the enhanced spine. The enhancement of normal marrow on MR images acquired after the intravenous administration of a gadolinium chelate presence of enhancement is easily appreciated when direct AID Blood 0024 / 5h3d$$$461 08-13-97 17:12:44 blda WBS: Blood
For personal use only. on November 16, 2017. by guest www.bloodjournal.org From comparison with the precontrast T1-weighted MR images is PLASMA CELL DYSCRASIAS made. 14 Plasma cell dyscrasias are a heterogeneous group of clini-The variegated pattern consists of innumerable small foci cal disorders characterized by the production of a specific of disease on a background of intact marrow (Fig 6) . 14 
The
Ig molecule that is unique for each patient. The role of MR small lesions of the variegated pattern are dark on T1imaging has been evaluated in each one of these disorders. weighted images and bright on T2-weighted images, and Solitary bone plasmacytoma. Approximately 2% of pathey enhance after the administration of intravenous contrast. tients with plasma cell dyscrasias have a solitary bone plas-MR imaging of the bone marrow has been particularly macytoma. 16 The diagnosis of solitary bone plasmacytoma studied in patients with hematologic malignancies. Large requires histologic evidence of plasma cell infiltration at a field-of-view coronal STIR images of the axial skeleton and single bony site, absence of clonal plasma cells at distant T1-weighted and fat-suppressed, T2-weighted fast spin echo, bone marrow sites, and a normal bone survey elsewhere. or STIR sagittal images of the spine are recommended for Although definitive radiotherapy with approximately 45 Gy the initial evaluation of the bone marrow. Axial images usually eradicates the local disease, the majority of patients should be acquired to evaluate the extent of extraosseous who present with solitary bone plasmacytoma will develop masses. Enhanced images may be obtained in selected cases multiple myeloma. [16] [17] [18] Progression to systemic disease in when findings on the first two sequences are unclear. The patients with solitary bone plasmacytoma has been attributed indications, the findings, and the uses of MR imaging will to growth of previously occult disease. be discussed separately for the most common hematologic MR imaging, with its superior contrast resolution, is the preferred imaging modality for the initial assessment and for malignancies. the follow-up of the osseous and extraosseous extent of a Multiple myeloma. A well-recognized contribution of MR imaging in the management of patients with multiple solitary bone plasmacytoma (Fig 7) . The results of early studies on the role of MR imaging in the initial clinical myeloma is the evaluation of patients with neurologic symptoms. Extraosseous mass from lytic lesions in the spine can staging of solitary bone plasmacytoma are promising. One study showed unsuspected lesions on spinal MR images in enter the spinal canal and compress the spinal cord. Prompt intervention is necessary to prevent permanent neurologic 4 of 12 patients with the diagnosis of solitary bone plasmacytoma ( Fig 8) . 19 Three of these patients developed systemic deficits. MR images of the spine can accurately assess the level and the extent of cord compression in less than 5 min-disease within 18 months from diagnosis. Another group of investigators reported similar findings in four of six patients utes (Fig 9) . Vertebral compression fractures are often present at diag-with the diagnosis of solitary plasmacytoma of the bone. 20 Whether such patients would benefit from early initiation of nosis or develop during the course of multiple myeloma. 14, 21 Recently, an increased incidence of spinal compression frac-treatment for multiple myeloma is not known and requires further study. MR imaging should be part of the staging tures was reported in patients with myeloma and more than 10 focal lesions or diffuse patterns of involvement on bone procedures in patients with solitary bone plasmacytoma to better assess the local extent of the tumor and define the marrow MR images of the spine. 22 Although MR imaging identified patients at high risk for development of spinal radiation portals and to search for other, unanticipated foci of disease. Because of the increased cost of the modality, collapses, it could not predict the level of spinal collapse. 22 The appearance of new or progressive compression frac-the study may be limited to the spine, where most lesions occur. T1-and T2-weighted fat-suppressed fast spin echo or tures during or after treatment for multiple myeloma does not necessarily imply local progression of the disease. 21 Res-STIR sagittal images usually suffice for a screening examination. The addition of coronal large field-of-view images of olution of the tumor may cause collapse of the unsupported vertebral body ( Fig 6) . Differentiation of a malignant from the axial skeleton may increase the yield of positive exams. AID Blood 0024 / 5h3d$$$461 08-13-97 17:12:44 blda WBS: Blood
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For personal use only. on November 16, 2017. by guest www.bloodjournal.org From and 50% of patients with diffuse MR patterns of multiple myeloma did not have lytic lesions on bone radiographs. The range of abnormal MR studies in patients with multiple myeloma varies from 50% for patients with indolent disease to 100% for patients with symptomatic disease. [24] [25] [26] [27] All three MR patterns of abnormal marrow have been observed in patients with multiple myeloma (Figs 4, 5, and 6). 14, [25] [26] [27] [28] [29] The focal lesion pattern is more frequently observed than the other two and is more often associated with lytic lesions on bone radiographs. 14 It is interesting to note that, in a recent series, only 12 (18%) of 66 focal myelomatous lesions on spinal MR images had corresponding lytic lesions on skeletal surveys. 14 The increased incidence of positive bone surveys in patients with focal MR patterns can be attributed to focal growth of dense plasma cell aggregates that produce local bone destruction.
Diffuse marrow involvement occurs in 25% of patients with multiple myeloma. 14 This pattern has been associated with lower hemoglobin values and higher percentages of Lytic bone lesions or demineralization occur at presentation in more than 80% of patients with multiple myeloma. Radiographic bone surveys have been part of the staging system for multiple myeloma for the last 20 years. 23 How- For personal use only. on November 16, 2017. by guest www.bloodjournal.org From mass myeloma are observed without treatment until there is evidence of disease progression. 31 A prospective study with 38 patients with asymptomatic myeloma of low tumor mass and negative skeletal surveys showed that 19 (50%) patients had evidence of marrow involvement on spinal MR images. 25 A similar analysis by Vande Berg et al 32, 33 showed involvement of the bone marrow on MR images in 29% of patients with stage I myeloma and in 19% of 35 patients with monoclonal gammopathy of undetermined significance (MGUS). The same investigators observed 37 patients with MGUS for a mean of 31 months: 4 of 7 patients with abnormal MR studies at diagnosis and none of 30 patients with normal initial MR studies showed evolutive disease at follow-up. 33 Abnormalities on MR images and the presence of Bence Jones protein in the urine were the only two parameters predictive of disease progression. Even when the tumor burden is very low, MR imaging may detect occult foci of myelomatous involvement and may predict a more precarious course of the disease.
Analysis of the prognostic significance of a positive MR bone marrow plasmacytosis. 14 The association of the diffuse MR pattern with more advanced disease supports an earlier report of a shorter survival rate for patients with multiple myeloma and negative bone radiographs. 14, 30 In that study, Smith et al 30 proposed that a more diffuse involvement of the bone marrow may account for the poor prognosis of their patients with negative skeletal surveys. Correlation of the levels and the activity of several cytokines (interleukin-6, interleukin-1a, tumor necrosis factor, etc, which are implicated in the process of bone destruction in myeloma) with the MR patterns of multiple myeloma may help explain the different fashions of spread of the disease. Before the prognostic significance of the MR patterns of marrow involvement in myeloma is established, further studies with a longterm follow-up need to be performed. or mild anemia. 31 Patients with asymptomatic, low tumor AID Blood 0024 / 5h3d$$$461 08-13-97 17:12:44 blda WBS: Blood
For personal use only. on November 16, 2017. by guest www.bloodjournal.org From study in patients with asymptomatic myeloma showed that A statistically significant relationship was shown between grades of contrast uptake by the abnormal marrow on en-an abnormal MR study of the spine identified patients with significantly shorter time to disease progression (median, hanced MR images and values of hemoglobin and lymphoplasmacytoid infiltration indices of the bone marrow. 38 16 months) when compared with patients with normal MR studies, who progressed at a median of 43 months. 31 The
Increasing grades of contrast uptake on enhanced MR images correlated with increasing tumor burden. A direct correlation prognostic value of an abnormal MR study was found to be independent of the presence or absence of standard adverse was found between decreased enhancement of the marrow on posttreatment MR images and degree of clinical re-prognostic factors for asymptomatic multiple myeloma. 31, 32 Furthermore, the pattern of marrow involvement on MR im-sponse. 38 The application of quantitative analysis of the involvement of the marrow on MR images to the assessment ages appeared to have a prognostic significance; patients with a diffuse or a focal MR pattern showed a tendency to of response to therapy in patients with macroglobulinemia may be of value in individual problem cases. progress earlier than patients with a variegated pattern. 31 Recently, a longitudinal study with 101 patients with asymp-LYMPHOPROLIFERATIVE DISORDERS tomatic myeloma showed that MR imaging of the spine was abnormal in 40% of patients with one adverse feature for Infiltration of the bone marrow occurs in 5% to 15% of progression to symptomatic myeloma and with an intermedipatients with Hodgkin's disease and in 25% to 40% of paate time to disease progression (median, 39 months). 34 In tients with non-Hodgkin's lymphoma. 40 The diagnosis of this particular group of patients, abnormal MR images helped bone marrow involvement is established with bone marrow identify those patients at risk for imminent complications. It biopsies, which are usually obtained from the posterior supeseems that early institution of chemotherapy in selected parior iliac crest. Sampling errors exist even with bilateral iliac tients with asymptomatic disease may be justified to reduce crest biopsies, because only a small volume of the bone morbidity among patients with myeloma at high risk for marrow is examined. 41 A 20% discordance between bilateral disease progression.
iliac crest bone marrow biopsies reflects the patchy nature Another application of MR imaging is the assessment of of bone marrow infiltration that occurs in the lymphomas. 41 ,42 the status of multiple myeloma after the initiation of treat-Bone marrow scintigraphy with several radiopharmaceutical ment. Changes in the abnormal marrow after successful treatagents can show an increase in hematopoiesis or defects at ment differ for each MR pattern and knowledge of these sites of bone marrow infiltrates, but it is limited by poor changes is necessary to interpret posttreatment MR imspatial resolution and lack of specificity. ages. 21, 35, 36 Our study of 20 patients with multiple myeloma MR imaging is a noninvasive technique that can assess who achieved a complete or partial response to treatment the status of large volumes of bone marrow. In patients with and who had pretreatment and posttreatment MR studies of lymphoma, MR imaging has been shown to be superior to the spine showed that patterns of complete response included bone marrow scintigraphy in the evaluation of the bone marresolution of marrow abnormality or persistent abnormality row. 40, 43 Shields et al 43 reported positive biopsy results in without enhancement or with peripheral rim enhancement 10% and positive results with scintigraphy in 29% and with only. 21 Conversion of a diffuse to a variegated or focal MR MR images in 39% of 38 patients with Hodgkin's disease. pattern and a decrease in the extent of marrow abnormality They concluded that MR imaging combined with histologic with persistent homogeneous enhancement was observed in examination of the bone marrow improves the evaluation of patients who achieved a partial response. 21 the bone marrow status and the staging of lymphoma. 43 with negative marrow biopsies (69%), a significantly poorer survival was shown for those patients with abnormal MR Waldenstrom macroglobulinemia is a low-grade lymphoid malignancy characterized by infiltration of the bone marrow, studies of the femoral marrow compared with patients with normal MR studies. 45 The diagnostic yield of the bone mar-lymph nodes, and spleen by abnormal lymphoplasmacytoid cells. 37 We found evidence of marrow involvement on the row biopsy can be increased if the biopsy site is selected with the aid of MR images. Nevertheless, if marrow involve-MR images of 91% of 23 patients with Waldenstrom disease (Fig 10) . 38 Duhem et al 39 found MR abnormalities in all ment is shown on skeletal MR images of patients with lymphoma, a clinical stage IV should be assigned to the studied patients with macroglobulinemia. In contrast to patients with multiple myeloma, a focal MR pattern was not patient. 40 MR images can also direct harvest procedures for autologous bone marrow transplantation to sites of relatively observed in patients with macroglobulinemia. 38 This observation is in keeping with the rarity of lytic bone lesions uninvolved marrow. 44 On T1-weighted MR images, lymphomatous involvement in this disease. The diffuse and variegated MR patterns in Waldenstrom disease do not differ from those observed in of the bone marrow is seen as diffuse, primarily heterogeneous replacement of the marrow and less frequently as multiple myeloma and reflect a more dispersed spread of the malignant cells in the bone marrow compared with focal MR focal marrow lesions (Figs 11 and 12) . 43 AID Blood 0024 / 5h3d$$0024 08-13-97 17:12:44 blda WBS: Blood
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MR imaging has been applied to the posttreatment followup of patients with lymphoma. Quantitative MR imaging with serial measurements of T1 relaxation times showed a decrease of the latter in patients who responded to treatment. 50,51 Variations in T2 relaxation times were not useful. We should stress here that a prolonged T1 relaxation time reflects increased cellularity, which, in patients with lymphoma, may be due to lymphomatous infiltration, fibrosis, or reactive hypercellular marrow. 50 The differential diag-
Fig 11. An 8-year-old boy with Burkitt's lymphoma and diffuse marrow involvement. Fat-suppressed, T2-weighted fast spin echo (3000/96, TR/TE) sagittal MR image of the lumbar spine shows heterogeneous signal intensity of the bone marrow and epidural extension of tumor (arrowheads) at the level of L5 and L2, with apparent preservation of the vertebral cortex.
on T1-weighted images after the intravenous administration of contrast, the abnormal marrow enhances. The MR patterns of lymphomatous involvement of the bone marrow may be indistinguishable from similar patterns in myeloma, leukemia, and other malignant or benign diseases of the bone marrow. MR imaging cannot differentiate between the different histologic subtypes of lymphoma.
Its superior contrast resolution compared with CT makes MR imaging the modality of choice for the demonstration of soft tissue involvement. We have observed that extraosseous tumor in patients with lymphoma often occurs without obvious destruction of the cortical bone, reflecting the permeative nature of the tumor. MR images may show extensive involvement of the marrow and extraosseous soft tissues, with tumor ''wrapped'' around an apparently intact bony As in lymphomatous involvement of the bone marrow, extraosseous extension of tumor may occur without obvious bone after treatment for lymphoma, may be difficult. Enhanced MR images of the marrow may help assess the posttreatment destruction ( Fig 5) . Changes on conventional radiographs, even when they do occur, are not specific. MR imaging appearance of the lymphomas. studies can differentiate chloromas from other complications THE ACUTE LEUKEMIAS of leukemia, such as osteomyelitis and hematoma. STIR or enhanced T1-weighted MR images facilitate the detection MR imaging has proved to be very sensitive for depicting of these tumors, which are usually isointense to the bone changes in the bone marrow in patients with acute leukemarrow on unenhanced T1-and T2-weighted sequences, and mia. [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] The diffuse MR pattern of marrow involvement is should be obtained whenever development of a chloroma is typical but not specific for the disease (Fig 5) . Histologic suspected. 65-67 On postcontrast MR images, enhancement of examination of the marrow remains essential for the diagnothe capsule of a forming abscess or enhancement of an insis and cell phenotyping of the leukemias. In acute leukeflammed intervertebral disc will aid the differential diagnosis mias, the evaluation of response to treatment requires serial of infection versus relapse of leukemia. bone marrow biopsies during the course of therapy. For this reason, investigators have focused on the prospect of MR APLASTIC ANEMIA AND MYELODYSPLASTIC imaging as a noninvasive means of assessing the posttreat-SYNDROMES ment status of the bone marrow.
Initial reports showed that serial measurements of bulk Aplastic anemia has a characteristic appearance on MR images because of the absence of cellular elements and the T1 relaxation times (from both fat and water components of the bone marrow) and serial measurements of fat and water presence of abundant fatty marrow. [68] [69] [70] [71] [72] [73] The signal intensity of the aplastic bone marrow on T1-and T2-weighted images fractions were helpful in differentiating responding from nonresponding patients with acute leukemias. 52-62 A decrease approaches that of subcutaneous fat. The aplastic marrow is excessively bright and, in most cases, is easily recognized in bulk T1 values or an increase in the fat fractions of the marrow after the first week of treatment were found to be from normal age-related marrow changes. Takagi et al 73 studied nine patients with aplastic anemia with MR images of in keeping with a favorable response. However, Vande Berg et al, 63 in a later, larger study with 29 patients with acute the femoral marrow. In all patients, on T1-weighted images the femoral marrow was either entirely fatty or predomi-myelogenous leukemia (AML), found that changes in posttreatment bulk T1 measurements did not differ significantly nantly fatty with small hypointense nodules. 73 Smith et al 72 reported significantly lower T1 values in four patients with in responding and nonresponding patients during and after the first induction course of treatment. They postulated that severe aplastic anemia who were studied with MR images of the lumbar spine, compared with a control group. However, ablation of the leukemic cells and regeneration of the marrow are two processes that may occur independently and may Olson et al 46 cautioned that changes of aplastic anemia may not be distinguished from normal fatty bone marrow at other both affect bulk T1 values of the marrow. The conclusions of Vande Berg et al 63 stress the high sensitivity of MR im-parts of the skeleton. An overlap of T1 measurements between normal and aplastic marrow was observed in the aging in depicting abnormalities in the bone marrow and its poor specificity and difficulty in differentiating posttherapy spines of three patients with aplastic anemia. 70 This overlap did not exist when fractions of fat in the bone marrow were changes from active disease. The same investigators recently reported that, although sequential quantitative MR imaging calculated with a phase contrast chemical imaging technique. 46, 69, 71 The characteristic fatty appearance of the aplas-was not useful in assessing the effect of treatment in patients with AML, it appeared to have value in predicting response tic marrow may not be observed in the presence of hemosiderosis, because deposition of iron causes a decrease in the in patients with acute lymphoid leukemia (ALL). 64 One explanation for the increasing sensitivity of MR images to signal of the bone marrow on T1-and, particularly on T2weighted images (Fig 13) . Knowledge of the patient's trans-detect residual disease in patients with ALL compared with patients with AML is based on inherent differences of fusion history is important for the interpretation of the MR findings in patients with aplastic anemia. lymphoid and myeloid cells. 65 The longer T1 values of lymphoid cells may enhance the differences in bulk T1 and,
The detection of either focal or diffuse loss of the bright signal of the aplastic marrow, in the absence of hemosid-thus, facilitate the detection of residual blasts. Quantitative analysis of dynamically enhanced MR images is under inves-erosis, may provide evidence for clonal disease (Fig 14) . Negendak et al 74 identified unexpected foci of hypercellular tigation and may prove to be useful in the assessment of the status of the bone marrow after treatment, because the degree marrow on MR images of the spine in eight patients with a clinical diagnosis of aplastic anemia. Seven of these patients and rate of contrast uptake depends on the cellularity and vascularity of the marrow. One of the complications of acute showed adjunctive evidence of myelodysplastic syndrome. Care should be taken to avoid misdiagnosing foci of regener-leukemia is the development of chloromas or granulocytic sarcomas. The chloromas, which are more frequently associ-ating hematopoietic marrow for clonal disease in patients with aplastic anemia who respond to treatment. Various MR ated with AML, occur in 4.7% of patients. 65 They are solid tumors composed of granulocyte precursor cells that arise techniques, including STIR images and contrast-enhanced images, may be used in an attempt to differentiate between in the bone marrow and spread to the extraosseous space. Extension of these tumors into the spinal canal may cause the two entities. The prognosis of patients with myelodysplastic syndromes compression of the spinal cord or the nerve roots ( Fig 5) . Polycythemia vera and myelofibrosis belong to the group of chronic myeloproliferative disorders. In patients with polycythemia vera, the bone marrow of the axial skeleton is diffusely and homogeneously hypointense on T1-weighted MR images and it is indistinguishable from the diffuse marrow abnormality observed in patients with leukemia or myeloma. 75 Foci of hypercellular marrow may appear in the peripheral skeleton as well. Kaplan et al 75 found that patients with polycythemia vera and nonfatty hypercellular marrow on MR images of the femoral epiphyses and greater trochanters had higher levels of serum lactate dehydrogenase and lower levels of serum cholesterol compared with patients with the same disease but with a normal fatty appearance of the proximal femurs.
In myelofibrosis, the bone marrow may be hypercellular or depleted of all hematopoietic elements. Fibrotic marrow is visualized as areas of markedly low signal on all MR and the frequency of evolution to acute leukemia varies. In a recent series with 85 patients with myelodysplastic syndromes, Takagi et al 73 found that the presence of extensive and uniform abnormality in the femoral marrow, with bright signal on corresponding STIR MR images, identified patients with a worse prognosis. These MR findings occured in 92% of patients with refractory anemia with excess blasts (RAEB) or with RAEB in transformation (RAEB-T), in all patients who developed AML, and in only 17% of patients with refractory anemia (RA) or RA with ring sideroblasts (RARS). The investigators concluded that, in patients with myelodysplastic syndromes, an increase in the extent of marrow abnormality and in its signal intensity on STIR images indicate progression of the disease. 73 In this group of disorders of the marrow, MR images, by actually providing infor- sequences (Fig 15) . 74, 75 Unless the characteristic appearance of fibrotic marrow is seen, myelofibrosis cannot be distinguished from other hematologic malignancies with MR images alone.
POSTTHERAPY CHANGES
The changes that occur in the bone marrow after chemotherapy for leukemia are known from histologic studies. 76 In the first week of treatment with chemotherapy, the marrow becomes very hypocellular with edema and dilated vascular sinuses. T1-weighted MR images of posttherapy necrosis of the marrow show a decrease in the signal of the bone marrow. On T2-weighted images, the marrow becomes bright, reflecting an increase in water content. After the first week, unilocular adipocytes (structured fat) produced from multilocular fat cells appear in the marrow. Subsequently, hematopoietic cells gather close to these areas of structured fat. From this time on, the marrow gradually becomes brighter, reflecting the increase in fat. Any deviation from this sequence of changes may suggest failure of response to treatment or relapse of the disease. The administration of hematopoietic growth factors may delay the fatty transformation of the bone marrow or may cause reconversion of fatty to hematopoietic marrow and simulate persistent or relapsing disease (Fig 16) . 77 Radiation therapy kills the hematopoietic cells in the marrow and destroys the vascular sinusoids. Several investigators have studied the changes that occur in the irradiated bone marrow with MR images. [78] [79] [80] [81] T1-weighted MR images immediately after the initiation of radiotherapy show a decrease in the signal intensity of the bone marrow because of necrosis and edema of the marrow. STIR images are more sensitive in depicting early postradiation changes in the marrow. 80 Increased signal intensity of the irradiated vertebral marrow was seen in 9 of 10 patients, with a peak incidence of the bone marrow gradually increases on T1-weighted MR AID Blood 0024 / 5h3d$$$461 08-13-97 17:12:44 blda WBS: Blood
For personal use only. on November 16, 2017. by guest www.bloodjournal.org From signal after treatment may be observed with nonresponding tumor, marrow edema, and regenerating hematopoietic marrow (Fig 18) . 83 A lesion that was enhancing intensely and homogeneously before treatment and ceases to enhance or demonstrates a peripheral rim of enhancement after treatment is in keeping with a treated, inactive lesion. Enhanced MR images may be helpful in the differentiation of regenerating hematopoietic marrow from relapse of the disease. Because fibrotic changes that may develop in the bone marrow after treatment may enhance, dynamically enhanced MR images, obtained within 30 seconds from the intravenous injection of contrast, were tried detect early, arterial enhancement associated with tumor vessels. 35 Dynamic images showing early enhancement (arterial phase) and early washout of contrast suggest the presence of residual tumor cells, whereas delayed and more prolonged patterns of enhancement suggest reactive changes. Dynamic MR imaging studies in patients with osteosarcoma and Ewing sarcoma showed that an interval of less than 6 seconds between arterial and tumoral enhancement correlated with the presence of residual viable tumor. 84 Erlemann et al 85 claim that dynamic MR imaging is superior to skeletal scintigraphy with an accuracy of 85.7% in assessing response of osteosarcoma and Ewing sarcoma to preoperative chemotherapy. Further studies are needed to evaluate the efficacy of dynamic MR imaging in the detection of minimal residual disease or early relapse in patients with hematologic malignancies.
COMPRESSION FRACTURES
In a patient who is being treated for a hematologic malignancy, the development of a spinal compression fracture presents the clinician with a serious diagnostic problem. During or after therapy, resolution of the tumor mass that had ered on posttreatment MR images of 29 patients with multiple myeloma in remission. 21 However, collapse may be due to progressive replacement of the vertebral body by uncon-images. The bright marrow is sharply limited to the radiation portals and is produced by the migration of fatty cells from trolled tumor (Fig 9) . Conventional radiographs and CT are not usually helpful in determining the etiology of the frac-adjacent nonirradiated areas (Fig 17) . On STIR images, the signal intensity of the radiated marrow gradually decreases. ture, if obvious signs of malignancy are not present. On MR images, edema and hemorrhage of the marrow in a recent Fatty replacement of the bone marrow is first seen around the basivertebral vein at the center of the vertebral body. 80 fracture of benign etiology may mimic findings of a fracture of malignant etiology. The characteristic bright appearance of the irradiated spine is nonreversible for doses equal to or higher than 30 to 40
There have been several attempts to determine the etiology of vertebral collapses with MR images. [86] [87] [88] [89] We recently stud-Gy, because destruction of the vascular sinusoids does not permit the migration of hematopoietic cells into the radiation ied the MR images of 98 vertebral collapses (51 malignant and 47 osteoporotic or posttraumatic). 88 Abnormality involv-field. 79 For doses less than 30 Gy, regeneration of the marrow may occur 1 year after radiation therapy. 78, 81, 82 ing the entire vertebral body, an epidural mass or a bulging contour of the vertebra, extension of the abnormality to the Before evaluating the posttherapy changes that are seen on MR images of the bone marrow, it is necessary to be pedicles, and a cervical or lumbosacral location were findings more frequently associated with malignant fractures (P familiar with the changes that occur in each MR pattern of abnormal marrow after successful treatment. The abnormaliõ .01). The accuracy of MR imaging in the diagnosis of a benign or malignant compression fracture approached 94% ties seen on the pretreatment T1-weighted MR images may not resolve even in complete responders. 21, 35 It is their mor-when this constellation of MR criteria was applied. 88 ment of the affected vertebra after the administration of intra-During the first posttransplantation days, marrow necrosis is seen as a decrease in the signal intensity of the marrow venous contrast are highly (100%) specific signs for malignant fractures. MR imaging is today the procedure of choice on T1-weighted images and as increased brightness on T2weighted images. Within 3 months from bone marrow for the evaluation of the cause of a vertebral body collapse. In cases with equivocal MR findings, a repeat study in 4 transplantation, a characteristic band pattern appears on T1weighted MR images of the spine. 90 This band pattern con-weeks should provide the answer: resolution of the changes will be seen in a benign fracture, whereas the changes will sists of a peripheral zone of dark signal and a central zone of bright signal. At histologic examination, the peripheral persist or progress in a malignant one. zone corresponded to repopulating hematopoietic marrow MR IMAGING IN BONE MARROW TRANSPLANTATION and the central zone to marrow fat. 90 Stevens et al 90 observed Bone marrow transplantation has been used for the treatthe band pattern in all but 1 of 15 patients within 90 days ment of hematologic and solid malignancies since the middle after bone marrow transplantation and up to a follow-up of of the 1950s. Patients who undergo bone marrow transplanta-14 months. In 1 patient with relapse of disease, the band tion are assessed with serial bone marrow biopsies and aspipattern evolved to a more homogeneous appearance of the rations. Because MR images provide a noninvasive means marrow. In our experience, the band pattern gradually of assessing large volumes of the bone marrow, they were evolves into a homogeneous appearance of the marrow after applied to the evaluation of the posttransplant patient (Figs successful bone marrow transplantation. 3 and 19). The interpretation of MR images of the bone MR imaging of the bone marrow has been used in the marrow in the posttransplant patient requires knowledge of selection of the bone marrow harvest site in candidates for the sequence of changes that occur in the marrow after transautologous bone marrow transplantation. MR imaging can identify disease in the marrow in patients with known hema-plantation.
AID Blood 0024 / 5h3d$$$461 08-13-97 17:12:44 blda WBS: Blood tologic malignancies and negative bilateral iliac crest bone monitoring peripheral blood cell counts. In a recent report marrow biopsies. 40, 44, 47, 91 Negendak and Soulen 91 found that on patients who underwent bone marrow MR imaging before 32% of 50 patients with lymphoma who were eligible for and after blood stem cell transplantation, high signal was bone marrow transplantation had abnormal MR studies. observed on STIR images during the period of marrow Forty-four percent of these patients relapsed at a median time aplasia and during marrow reconstitution. 83 Extracellular of 9.5 months after autologous bone marrow transplantation, edema may be difficult to differentiate from increased celluwhereas 49% of patients with negative MR studies relapsed larity on T1-and T2-weighted MR images alone. Quantitaat a median time of 14.6 months. 91 These data suggest that tive techniques and contrast-enhanced MR sequences are relapse of the disease after bone marrow transplantation may being studied in an attempt to introduce a noninvasive means not be due to reinfusion of malignant cells in the marrow of directly assessing the cellular population of the marrow. but to failure to eradicate the malignant cells before harvest-Results on the role of molecular markers for monitoring ing the marrow. MR imaging of the marrow is a useful changes that occur in the marrow are promising, but, so far, adjunct to bone marrow biopsy for patients who are candithere are no publications comparing their merits relative to dates for bone marrow transplantation and, in particular, for those of bone marrow MR imaging. 92 patients with lymphoma, a disease with a well-known patchy mode of infiltration of the bone marrow.
CONCLUSIONS
Today, peripheral blood stem cell transplantation is the MR imaging has become an important noninvasive tool preferred technique for bone marrow transplantation. Patients who undergo stem cell transplantation are followed by that can provide the clinician with important information for AID Blood 0024 / 5h3d$$$461 08-13-97 17:12:44 blda WBS: Blood
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